These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 30953000)

  • 1. Alpha-galactosylceramide enhances mucosal immunity to oral whole-cell cholera vaccines.
    Davitt CJH; Longet S; Albutti A; Aversa V; Nordqvist S; Hackett B; McEntee CP; Rosa M; Coulter IS; Lebens M; Tobias J; Holmgren J; Lavelle EC
    Mucosal Immunol; 2019 Jul; 12(4):1055-1064. PubMed ID: 30953000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sublingual Adjuvant Delivery by a Live Attenuated Vibrio cholerae-Based Antigen Presentation Platform.
    Liao J; Gibson JA; Pickering BS; Watnick PI
    mSphere; 2018 Jun; 3(3):. PubMed ID: 29875145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transient Intestinal Colonization by a Live-Attenuated Oral Cholera Vaccine Induces Protective Immune Responses in Streptomycin-Treated Mice.
    Fakoya B; Sit B; Waldor MK
    J Bacteriol; 2020 Nov; 202(24):. PubMed ID: 32540930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Construction of novel vaccine strains of Vibrio cholerae co-expressing the Inaba and Ogawa serotype antigens.
    Lebens M; Karlsson SL; Källgård S; Blomquist M; Ekman A; Nygren E; Holmgren J
    Vaccine; 2011 Oct; 29(43):7505-13. PubMed ID: 21807059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gut Microbiota and Development of Vibrio cholerae-Specific Long-Term Memory B Cells in Adults after Whole-Cell Killed Oral Cholera Vaccine.
    Chac D; Bhuiyan TR; Saha A; Alam MM; Salma U; Jahan N; Chowdhury F; Khan AI; Ryan ET; LaRocque R; Harris JB; Qadri F; Weil AA
    Infect Immun; 2021 Aug; 89(9):e0021721. PubMed ID: 34228490
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Robust gut associated vaccine-specific antibody-secreting cell responses are detected at the mucosal surface of Bangladeshi subjects after immunization with an oral killed bivalent V. cholerae O1/O139 whole cell cholera vaccine: comparison with other mucosal and systemic responses.
    Shamsuzzaman S; Ahmed T; Mannoor K; Begum YA; Bardhan PK; Sack RB; Sack DA; Svennerholm AM; Holmgren J; Qadri F
    Vaccine; 2009 Feb; 27(9):1386-92. PubMed ID: 19146897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-bacterial and anti-toxic immunity induced by a killed whole-cell-cholera toxin B subunit cholera vaccine is essential for protection against lethal bacterial infection in mouse pulmonary cholera model.
    Kang SS; Yang JS; Kim KW; Yun CH; Holmgren J; Czerkinsky C; Han SH
    Mucosal Immunol; 2013 Jul; 6(4):826-37. PubMed ID: 23187318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selenium Nanoparticles Induce Potent Protective Immune Responses against
    Raahati Z; Bakhshi B; Najar-Peerayeh S
    J Immunol Res; 2020; 2020():8874288. PubMed ID: 33490291
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral immunization with a probiotic cholera vaccine induces broad protective immunity against Vibrio cholerae colonization and disease in mice.
    Sit B; Zhang T; Fakoya B; Akter A; Biswas R; Ryan ET; Waldor MK
    PLoS Negl Trop Dis; 2019 May; 13(5):e0007417. PubMed ID: 31150386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcutaneous immunization with a Vibrio cholerae O1 Ogawa synthetic hexasaccharide conjugate following oral whole-cell cholera vaccination boosts vibriocidal responses and induces protective immunity in mice.
    Tarique AA; Kalsy A; Arifuzzaman M; Rollins SM; Charles RC; Leung DT; Harris JB; Larocque RC; Sheikh A; Bhuiyan MS; Saksena R; Clements JD; Calderwood SB; Qadri F; Kovác P; Ryan ET
    Clin Vaccine Immunol; 2012 Apr; 19(4):594-602. PubMed ID: 22357651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of humoral and cellular immune responses against Vibrio cholerae using oral immunization by multi-epitope-phage-based vaccine.
    Ghafouri E; Fadaie M; Amirkhani Z; Esmaeilifallah M; Rahimmanesh I; Hosseini N; Hejazi H; Khanahmad H
    Int Immunopharmacol; 2024 Jun; 134():112160. PubMed ID: 38710117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A thermostable, dry formulation inactivated Hikojima whole cell/cholera toxin B subunit oral cholera vaccine.
    Terrinoni M; Nordqvist SL; Löfstrand M; Nilsson F; Källgård S; Sharma T; Lebens MR; Holmgren J
    Vaccine; 2023 May; 41(21):3347-3357. PubMed ID: 37085452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CpG DNA, liposome and refined antigen oral cholera vaccine.
    Leelawongtawon R; Somroop S; Chaisri U; Tongtawe P; Chongsa-nguan M; Kalambaheti T; Tapchaisri P; Pichyangkul S; Sakolvaree Y; Kurazono H; Hayashi H; Chaicumpa W
    Asian Pac J Allergy Immunol; 2003 Dec; 21(4):231-9. PubMed ID: 15198341
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral vaccination using microdevices to deliver α-GalCer adjuvanted vaccine afford a mucosal immune response.
    Carlsen PHR; Kjeldsen RB; Pedersen GK; Christensen D; Nielsen LH; Boisen A
    J Control Release; 2023 Jan; 353():134-146. PubMed ID: 36372387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The roles of mesoporous silica and carbon nanoparticles in antigen stability and intensity of immune response against recombinant subunit B of cholera toxin in a rabbit animal model.
    Karimi Bavandpour A; Bakhshi B; Najar-Peerayeh S
    Int J Pharm; 2020 Jan; 573():118868. PubMed ID: 31765785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibody-secreting cell responses after Vibrio cholerae O1 infection and oral cholera vaccination in adults in Bangladesh.
    Rahman A; Rashu R; Bhuiyan TR; Chowdhury F; Khan AI; Islam K; LaRocque RC; Ryan ET; Wrammert J; Calderwood SB; Qadri F; Harris JB
    Clin Vaccine Immunol; 2013 Oct; 20(10):1592-8. PubMed ID: 23945156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cholera as a model for research on mucosal immunity and development of oral vaccines.
    Holmgren J; Czerkinsky C
    Curr Opin Immunol; 1992 Aug; 4(4):387-91. PubMed ID: 1388838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intramuscular delivery of a cholera DNA vaccine primes both systemic and mucosal protective antibody responses against cholera.
    Xu G; Wang S; Zhuang L; Hackett A; Gu L; Zhang L; Zhang C; Wang H; Huang Z; Lu S
    Vaccine; 2009 Jun; 27(29):3821-30. PubMed ID: 19443090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mucosal immunization with Vibrio cholerae outer membrane vesicles provides maternal protection mediated by antilipopolysaccharide antibodies that inhibit bacterial motility.
    Bishop AL; Schild S; Patimalla B; Klein B; Camilli A
    Infect Immun; 2010 Oct; 78(10):4402-20. PubMed ID: 20679439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mucosal and systemic immune responses in humans after primary and booster immunizations with orally administered invasive and noninvasive live attenuated bacteria.
    Viret JF; Favre D; Wegmüller B; Herzog C; Que JU; Cryz SJ; Lang AB
    Infect Immun; 1999 Jul; 67(7):3680-5. PubMed ID: 10377160
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.